![]() |
市場調查報告書
商品編碼
2040885
眼科包裝市場預測至2034年-按產品類型、類別、劑量、原料、最終使用者和地區分類的全球分析Ophthalmic Packaging Market Forecasts to 2034 - Global Analysis By Product (Plastic Droptainer Bottles, Glass Dropper Bottles, Metal Collapsible Tubes, Plastic Collapsible Tubes and Other Products), Type, Dose, Raw Material, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球眼科包裝市場規模將達到 154.7 億美元,在預測期內以 10.4% 的複合年成長率成長,到 2034 年將達到 341.4 億美元。
眼科包裝在保護和妥善分發珍貴的眼藥水方面發揮著至關重要的作用。這些專用包裝經過精心設計,充分考慮了無菌性、準確性和易用性等因素。通常,它們在無菌環境中密封保存,以確保產品有效性,並且眼科包裝中使用的材料符合相關法規標準。清晰的標籤傳達了正確的使用說明,防篡改設計增強了消費者的信心。符合人體工學的包裝設計以使用者便利性為優先考慮,方便滴眼和儲存。
根據 2018 年美國人口普查,約有 1,670 萬至 5,020 萬美國人患有乾眼症,佔總人口的 5% 至 15%。
眼科疾病增加
隨著白內障和青光眼等眼科疾病在全球範圍內的發病率不斷上升,對能夠確保眼科產品安全、有效且正確使用的專用包裝的需求日益成長。這推動了包裝設計的創新,使其融合了先進的藥物輸送系統和防篡改措施等功能。此外,日益嚴格的監管標準以及消費者對便捷易用包裝的需求不斷成長,也進一步促進了眼科包裝市場的發展。
保存期限短
包裝解決方案必須確保產品穩定性並防止快速劣化,這增加了複雜性和成本。製造商面臨著滿足嚴格要求以維持敏感配方功效的挑戰。較短的保存期限要求快速生產和分銷,從而推高了營運成本。此外,頻繁的產品更換也增加了庫存管理的負擔。這些限制不僅限制了包裝設計的柔軟性,而且阻礙了成本效益並影響了利潤率。
消費者對眼部健康的認知不斷提高
隨著消費者眼部健康意識的提高,眼部護理的重要性日益凸顯,導致眼科產品需求激增。因此,包裝在吸引和留住顧客方面發揮著至關重要的作用,它能夠確保產品的安全性、有效性和便利性。品牌商必須投資於美觀且資訊豐富的包裝,以傳達其眼科護理產品的益處,從而建立消費者信任並推動市場成長。
原料取得困難和激烈的競爭
滿足嚴格的監管要求需要進行大量的測試、文件編制和遵守複雜的指導方針,從而導致研發和生產成本增加。這對中小企業來說尤其沉重,並可能阻礙其進入市場。為了遵守不斷變化的法規,企業需要不斷更新產品,這進一步加劇了資源壓力。此外,嚴格的標準可能會限制柔軟性和創新,從而抑制市場成長,因為企業會優先考慮合規性而非探索新的包裝解決方案。
新冠疫情的影響
封鎖措施、旅行限制以及消費者優先事項的轉變導致非必需品需求下降,其中包括某些眼科產品。此外,醫療資源集中用於應對疫情相關問題也降低了人們對常規眼科護理的興趣。這些因素共同導致了眼科包裝市場出現暫時性下滑。
在預測期內,塑膠滴管瓶細分市場預計將成為最大的細分市場。
預計塑膠滴管瓶市場將實現盈利成長。這些輕便耐用的容器為眼科溶液提供安全的環境,防止其污染並保持其有效性。塑膠滴管瓶的採用提高了眼科產品的易用性並延長了其保存期限。其成本效益和易於生產也是推動市場成長的因素。
在預測期內,眼部乳液細分市場預計將呈現最高的複合年成長率。
預計在預測期內,眼部乳液細分市場將呈現最高的複合年成長率。這是因為隨著眼部乳液在治療和美容領域的應用日益普及,其包裝要求也隨之改變。市場對能夠確保產品品質和用戶便利性的創新包裝解決方案的需求激增。製造商正日益致力於開發易於使用、密封性佳且遮光的包裝,以保護眼部乳液的活性成分。因此,眼部乳液細分市場的蓬勃發展正在推動眼科包裝領域的創新。
由於眼科疾病發病率上升、眼科產品出口成長、眼科專案研發投入增加以及針對參數化包裝的嚴格監管政策,預計北美將在預測期內佔據最大的市場佔有率。例如,2023年2月,West Pharmaceutical Services宣布擴大與康寧公司的現有合作關係。此次合作擴展包括獲得康寧Valour管瓶的獨家經銷權,並推出其旗艦產品West Ready Pack,該產品包含康寧Valour即用管瓶。
預計亞太地區在預測期內將呈現最高的複合年成長率,這主要得益於市場對快速可靠、滿足安全要求、提升患者舒適度、採用防篡改技術並提供高品質產品及保護的包裝解決方案的需求。例如,為滿足日益成長的市場需求,肖特公司於2023年3月在印度開始生產琥珀色醫用玻璃。此舉擴大了硼矽酸玻璃的供應範圍,惠及印度和亞洲的製藥包裝製造商。
According to Stratistics MRC, the Global Ophthalmic Packaging Market is accounted for $15.47 billion in 2026 and is expected to reach $34.14 billion by 2034 growing at a CAGR of 10.4% during the forecast period. Ophthalmic packaging plays a crucial role in protecting and delivering sensitive eye medications. These specialized packages are designed with precision and care, considering factors like sterility, accuracy, and ease of use. These are typically sterile and sealed to maintain product efficacy, ophthalmic packaging employs materials that meet regulatory standards. Clear labeling facilitates proper usage instructions, while tamper-evident features enhance consumer confidence. The packaging's ergonomic design prioritizes user convenience, supporting easy dispensing and storage.
According to the USA General Population Cross-sectional Study, 2018, around 16.7 to 50.2 million Americans have a dry eye disease, accounting for 5% to 15% of the total population.
Increase in eye-related disorders and conditions
As the prevalence of ailments like cataracts and glaucoma rises globally, there is an increased demand for specialized packaging that ensures the safety, efficacy, and proper administration of ophthalmic products. This has led to innovations in packaging design, incorporating features like advanced drug delivery systems and tamper-evident measures. The growing need for compliance with stringent regulatory standards and the emphasis on consumer-friendly, convenient packaging further propel the Ophthalmic Packaging market
Limited shelf life
Packaging solutions must ensure product stability and prevent deterioration within a short timeframe, increasing complexity and cost. Manufacturers face challenges in meeting stringent requirements for preserving the efficacy of sensitive formulations. Short shelf life necessitates rapid production and distribution, raising operational costs. Additionally, frequent product turnover places pressure on inventory management. This constraint not only limits the flexibility of packaging design but also hinders cost-effectiveness, impacting profit margins.
Growing awareness among consumers regarding eye health
Increased awareness prompts consumers to prioritize eye care, leading to a surge in demand for ophthalmic products. Consequently, packaging plays a crucial role in attracting and retaining customers by ensuring product safety, efficacy, and convenience. Brands are compelled to invest in visually appealing and informative packaging to communicate the benefits of their eye care products, fostering consumer trust boosting the market growth.
Availability of raw materials with intense competition
Meeting rigorous regulatory requirements demands extensive testing, documentation, and adherence to complex guidelines, escalating development and production costs. Small and medium-sized enterprises may find it particularly burdensome, hindering their entry into the market. The need for continuous updates to comply with evolving regulations further strains resources. Additionally, the stringent standards may limit flexibility and innovation, as companies prioritize meeting compliance over exploring novel packaging solutions hindering the market growth.
Covid-19 Impact
Lockdowns, travel restrictions, and a shift in consumer priorities have caused a decline in demand for non-essential goods, including certain ophthalmic products. Additionally, the focus on healthcare resources for pandemic-related issues has diverted attention from routine eye care. These factors have collectively resulted in a temporary downturn for the Ophthalmic Packaging market
The plastic droptainer bottles segment is expected to be the largest during the forecast period
The plastic droptainer bottles segment is estimated to have a lucrative growth, as these lightweight and durable containers provide a secure environment for ophthalmic solutions, protecting them from contamination and preserving their efficacy. The adoption of plastic droptainer bottles has led to improved user-friendliness and increased shelf life of ophthalmic products. Their cost-effectiveness and ease of manufacturing have also contributed to market growth.
The eye lotions segment is expected to have the highest CAGR during the forecast period
The eye lotions segment is anticipated to witness the highest CAGR growth during the forecast period, as these formulations gain popularity for their therapeutic and cosmetic applications, packaging requirements have evolved. Demand for innovative packaging solutions, ensuring product integrity and user convenience, has surged. Manufacturers are increasingly focusing on creating user-friendly, airtight, and light-protective packaging to preserve the potency of eye lotions. The dynamic growth in the eye lotion segment has consequently stimulated innovation in Ophthalmic Packaging
North America is projected to hold the largest market share during the forecast period owing to the owing to the rising prevalence of ocular disorders, the growing export of ophthalmic products, increasing investment in R&D specific to the ophthalmic field, and stringent regulatory policies in parametrical packaging. For instance, in February 2023, West Pharmaceutical Services announced the expansion of its current collaboration with Corning. This expansion included exclusive rights to distribute Corning Valour glass vials. It also involved launching the company's primary product, West Ready Pack, containing Corning Valour RTU vials.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to owing to the need for speedy and reliable packaging solutions that fulfil a combination of security requirements, enhance patient comfort, comprise tamper-evident technology, and provide high-quality products and product protection. For instance, in March 2023, SCHOTT launched the production of amber medical glass in India to address rising demand. This initiative extended the availability of borosilicate glass variants to pharma packaging producers in India and Asia.
Key players in the market
Some of the key players in the Ophthalmic Packaging Market include SCHOTT AG, West Pharmaceutical Services, Inc., Mitotech, SA, Akorn, Inc., Santen Pharmaceutical Co., Amcor, Bausch & Lomb Incorporated, Bayer AG, Teva Pharmaceutical Industries Ltd., Gerresheimer AG, Novartis AG, ALLERGAN, Johnson & Johnson Vision, AptarGroup, Inc., F. Hoffmann-La Roche Ltd., Aerie Pharmaceuticals, INC and Merck Sharp & Dohme Corp.
In November 2023, Amcor and NOVA Chemicals announce agreement to source mechanically recycled polyethylene. Increasing the use of rPE in flexible packaging applications is an important element of Amcor's commitment to support packaging circularity.
In July 2023, Santen Agrees to License Agreements and Asset Transfer for its Pharmaceutical Products in North America. Under the terms of the agreement, Santen grants Visiox exclusive rights in the U.S. for product manufacturing and commercialization of OMLONTI?. Santen is eligible to receive sales milestone payments, as well as royalties on net U.S. sales of OMLONTI?.
In July 2022, Mitotech S.A, announced entering a partnership agreement with Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Mitotech S.A, a Luxembourg based clinical stage biotechnology company, announced entering a partnership agreement with Essex Bio-Investment for Phase 3 clinical program.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.